Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.1%
    Check dated 2025-12-01T16:17:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:13:22.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removal of the general government funding and operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:10:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content appears unchanged. The page continues to present study details for NCT04695470.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:32.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T07:14:18.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated page to version v3.1.0 with a new contact-like entry (zhouap1825@126.com) and an added numeric identifier; the old version tag v3.0.2 was removed. Overall, the substantive content appears largely unchanged; versioning and contact information are the primary changes.
    Difference
    0.1%
    Check dated 2025-09-28T02:57:24.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.